Late-breaking abstract: Phase 2a randomized placebo-controlled trial of the oral prostaglandin D2 receptor (DP2/ CRTh2) antagonist QAWo39 in eosinophilic asthma
暂无分享,去创建一个
I. Pavord | C. Brightling | A. Wardlaw | V. Mistry | S. Gonem | M. Bourne | A. Mansur | R. Hartley | S. Siddiqui | Richard A Kay | A. Singapuri | R. Berair | Chengxing Lu | B. Holzhauer | G. Bacher | Marie Laurencin | M. Laurencin